Wave Life Sciences (WVE) Total Current Liabilities (2016 - 2026)
Wave Life Sciences (WVE) has disclosed Total Current Liabilities for 12 consecutive years, with $49.8 million as the latest value for Q1 2026.
- For Q1 2026, Total Current Liabilities fell 42.96% year-over-year to $49.8 million; the TTM value through Mar 2026 reached $49.8 million, down 42.96%, while the annual FY2025 figure was $95.1 million, 14.32% down from the prior year.
- Total Current Liabilities hit $49.8 million in Q1 2026 for Wave Life Sciences, down from $95.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $186.4 million in Q4 2023 and bottomed at $49.8 million in Q1 2026.
- Average Total Current Liabilities over 5 years is $108.5 million, with a median of $95.1 million recorded in 2025.
- Year-over-year, Total Current Liabilities surged 160.68% in 2023 and then crashed 49.69% in 2025.
- Wave Life Sciences' Total Current Liabilities stood at $71.5 million in 2022, then skyrocketed by 160.68% to $186.4 million in 2023, then tumbled by 40.49% to $111.0 million in 2024, then decreased by 14.32% to $95.1 million in 2025, then crashed by 47.58% to $49.8 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods came in at $49.8 million, $95.1 million, and $85.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.